Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
M2R-001 by XCELL Medical Solutions for Muscle Injury: Likelihood of Approval
M2R-001 is under clinical development by XCELL Medical Solutions and currently in Phase II for Muscle Injury. According to GlobalData,...